Pulmonx Corp (LUNG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,231 | -20,703 | -18,479 | N/A | N/A |
| Depreciation Amortization | 1,416 | 332 | 306 | N/A | N/A |
| Accounts receivable | 1,457 | -2,524 | -262 | N/A | N/A |
| Accounts payable and accrued liabilities | 592 | 524 | -648 | N/A | N/A |
| Other Working Capital | -4,787 | -2,401 | -1,523 | N/A | N/A |
| Other Operating Activity | 2,920 | 4,007 | 2,212 | 0 | 0 |
| Operating Cash Flow | $-30,633 | $-20,765 | $-18,394 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,605 | -13,513 | 500 | N/A | N/A |
| PPE Investments | -911 | -720 | -300 | N/A | N/A |
| Investing Cash Flow | $12,694 | $-14,233 | $200 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 52,907 | 6,000 | 12,000 | N/A | N/A |
| Debt Repayment | -19,914 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 206,358 | 528 | 114 | N/A | N/A |
| Common Stock Repurchased | -21 | -12 | N/A | N/A | N/A |
| Other Financing Activity | -4,499 | 39,103 | 0 | 0 | 0 |
| Financing Cash Flow | $234,831 | $45,619 | $12,114 | $N/A | $N/A |
| Exchange Rate Effect | 133 | 22 | 154 | N/A | N/A |
| Beginning Cash Position | 14,767 | 4,124 | 10,050 | N/A | N/A |
| End Cash Position | 231,792 | 14,767 | 4,124 | N/A | N/A |
| Net Cash Flow | $217,025 | $10,643 | $-5,926 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,633 | -20,765 | -18,394 | N/A | N/A |
| Capital Expenditure | -911 | -720 | -316 | N/A | N/A |
| Free Cash Flow | -31,544 | -21,485 | -18,710 | 0 | 0 |